Increasing Her2/Centromere17(CEP17) ratio predicts for greater sensitivity to trastuzumab based therapy in metastatic breast cancer (MBC)

✍ Scribed by S. Howell; A. Sawyerr; A. Cramer; D. Ryder; A.M. Wardley

• Book ID: 119598287
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 56 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)70795-x